BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/25/2014 2:47:00 PM | Browse: 963 | Download: 1020
Publication Name World Journal of Gastroenterology
Manuscript ID 7135
Country Italy
Received
2013-11-05 22:28
Peer-Review Started
2013-11-06 16:01
To Make the First Decision
2013-12-26 11:30
Return for Revision
2014-02-11 09:43
Revised
2014-03-13 04:24
Second Decision
2014-05-19 11:02
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-05-19 11:25
Articles in Press
2014-05-23 09:57
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-07-21 14:57
Publish the Manuscript Online
2014-08-07 10:34
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Topic Highlights
Article Title p38α MAPK pathway: A key factor in colorectal cancer therapy and chemoresistance
Manuscript Source Invited Manuscript
All Author List Valentina Grossi, Alessia Peserico, Tugsan Tezil and Cristiano Simone
Funding Agency and Grant Number
Funding Agency Grant Number
Italian Association for Cancer Research (AIRC) fellowship to Grossi V
Italian Foundation for Cancer Research (FIRC) fellowships to Peserico A and Tezil T
Italian Association for Cancer Research (AIRC) IG10177 (to Simone C)
FIRB “Futuro in Ricerca” from the Italian MIUR RBFR12VP3Q_003 (to Simone C)
Corresponding Author Cristiano Simone, MD, PhD, Division of Medical Genetics, Department of Biomedical Sciences and Human Oncology (DIMO), University of Bari “Aldo Moro”, Via Nazionale 8/A, Bari 70124, Italy. simone@negrisud.it
Key Words p38 mitogen-activated protein kinase; Chemoresistance; Molecularly-targeted drugs; Colorectal cancer; Cell death
Core Tip The pro-apoptotic effects of p38α activation are long recognized; however, a significant number of reports describes the involvement of p38α in cancer-specific metabolism, survival, proliferation, and chemoresistance of colorectal cancer cells and tissues. p38α blockade exerts its chemosensitizing effects through nuclear accumulation of FoxO3A and activation of its pro-apoptotic gene expression program, thereby improving the efficacy of anti-cancer treatments. Apoptosis induction upon p38α inhibition requires Bax, which may thus serve as a predictive bio-marker for p38α-targeted therapy response. The novel role described for the p38-FoxO3A axis in chemoresistance might offer new options for combined therapies and personalized medicine approaches.
Publish Date 2014-08-07 10:34
Citation Grossi V, Peserico A, Tezil T, Simone C. p38α MAPK pathway: A key factor in colorectal cancer therapy and chemoresistance. World J Gastroenterol 2014; 20(29): 9744-9758
URL http://www.wjgnet.com/1007-9327/full/v20/i29/9744.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i29.9744
Full Article (PDF) WJG-20-9744.pdf
Full Article (Word) WJG-20-9744.doc
Manuscript File 7135-Review.docx
Answering Reviewers 7135-Answering reviewers.pdf
Copyright License Agreement 7135-Copyright Assignment.pdf
Non-Native Speakers of English Editing Certificate 7135-Language certificate.pdf
Peer-review Report 7135-Peer review.pdf
Scientific Editor Work List 7135-Scientific editor work list.pdf